[ET Net News Agency, 8 October 2026] HANSOH PHARMA (03692) fell 5.1% to HK$32.2.
It hits an intra-day low of HK$32.2, dipping below the 100-D SMA of HK$32.349, and an intra-day high of HK$34.56. The total shares traded was 10.86 million, with a value of HK$358.57m. The active buy/sell ratio is 59:41, with net buying turnover of HK$59.96m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$12.05m, with volume weighted average price of HK$33.166. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of HK$32.5m, with volume weighted average price of HK$32.98. The stock has fallen a combined 6.9% over the past 2 consecutive trading days.
The Hang Seng Index now fell 353 points, or 1.5% to 23,776; the Hang Seng China Enterprises Index now fell 71 points, or 0.9% to 8,011.
Basic Information| Nominal | 32.200 | % Chg | -5.07% |
| High | 34.560 | Low | 32.200 |
| Shares Tr | 10.86m | Turnover | 358.57m |
| 10-D SMA | 33.848 | %H.V | 41.615 |
| 20-D SMA | 33.953 | VWAP | 33.030 |
| 50-D SMA | 33.633 | RSI14 | 41.065 |
Status: Dipping below the 100-D SMA, active buy/sell ratio is 59:41, with net buying turnover of HK$59.96m, falling a combined 6.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 32.200 | -5.07 |
| SIHUAN PHARM (00460) | 0.710 | -0.70 |
| GRAND PHARMA (00512) | 4.755 | -1.45 |
| SBP GROUP (01177) | 5.495 | -3.17 |
| HENGRUI PHARMA (01276) | 48.280 | -1.75 |
| LIVZON PHARMA (01513) | 21.260 | -2.21 |
| LUYE PHARMA (02186) | 1.770 | -1.12 |
| FOSUN PHARMA (02196) | 17.900 | -1.59 |
| SH PHARMA (02607) | 10.890 | +0.28 |
| CHINARES PHARMA (03320) | 4.340 | +1.17 |
(ed)
Nominal 
